Adrian Jubb, MD PhD
Adrian Jubb, MD PhD
23andMe
Verified email at 23andme.com - Homepage
Title
Cited by
Cited by
Year
Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal …
AM Jubb, HI Hurwitz, W Bai, EB Holmgren, P Tobin, AS Guerrero, ...
Journal of clinical oncology 24 (2), 217-227, 2006
4282006
Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer
RS Herbst, SG Eckhardt, R Kurzrock, S Ebbinghaus, PJ O’Dwyer, ...
Clinical Oncology, 2006
3952006
Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab
WL Ince, AM Jubb, SN Holden, EB Holmgren, P Tobin, M Sridhar, ...
Journal of the National Cancer Institute 97 (13), 981-989, 2005
3622005
Biomarkers to predict the clinical efficacy of bevacizumab in cancer
AM Jubb, AL Harris
The lancet oncology 11 (12), 1172-1183, 2010
3162010
Predicting benefit from anti-angiogenic agents in malignancy
AM Jubb, AJ Oates, S Holden, H Koeppen
Nature Reviews Cancer 6 (8), 626-635, 2006
2702006
The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients
Z Jiang, S Jhunjhunwala, J Liu, PM Haverty, MI Kennemer, Y Guan, ...
Genome research 22 (4), 593-601, 2012
2152012
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
CC Ong, AM Jubb, PM Haverty, W Zhou, V Tran, T Truong, H Turley, ...
Proceedings of the National Academy of Sciences 108 (17), 7177-7182, 2011
1942011
Predictive impact of circulating vascular endothelial growth factor in four phase III trials evaluating bevacizumab
PS Hegde, AM Jubb, D Chen, NF Li, YG Meng, C Bernaards, R Elliott, ...
Clinical Cancer Research 19 (4), 929-937, 2013
1802013
Neuropilin‐1 expression in cancer and development
AM Jubb, LA Strickland, SD Liu, J Mak, M Schmidt, H Koeppen
The Journal of pathology 226 (1), 50-60, 2012
1742012
The histone demethylase JMJD2B is regulated by estrogen receptor α and hypoxia, and is a key mediator of estrogen induced growth
J Yang, AM Jubb, L Pike, FM Buffa, H Turley, D Baban, R Leek, KC Gatter, ...
Cancer research 70 (16), 6456-6466, 2010
1532010
Expression of vascular endothelial growth factor, hypoxia inducible factor 1α, and carbonic anhydrase IX in human tumours
AM Jubb, TQ Pham, AM Hanby, GD Frantz, FV Peale, TD Wu, ...
Journal of clinical pathology 57 (5), 504-512, 2004
1532004
Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers
D Gray, AM Jubb, D Hogue, P Dowd, N Kljavin, S Yi, W Bai, G Frantz, ...
Cancer research 65 (21), 9751-9761, 2005
1462005
Methylation and colorectal cancer
AM Jubb, SM Bell, P Quirke
The Journal of pathology 195 (1), 111-134, 2001
1462001
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
RN Fuji, M Flagella, M Baca, MAS Baptista, J Brodbeck, BK Chan, ...
Science translational medicine 7 (273), 273ra15-273ra15, 2015
1412015
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
AM Jubb, FM Buffa, AL Harris
Journal of cellular and molecular medicine 14 (1‐2), 18-29, 2010
1322010
Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer
AM Jubb, H Turley, HC Moeller, G Steers, C Han, JL Li, R Leek, EY Tan, ...
British journal of cancer 101 (10), 1749-1757, 2009
1272009
Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia
AM Jubb, S Chalasani, GD Frantz, R Smits, HI Grabsch, V Kavi, ...
Oncogene 25 (24), 3445-3457, 2006
1212006
p21-Activated kinase 1 is required for efficient tumor formation and progression in a Ras-mediated skin cancer model
HY Chow, AM Jubb, JN Koch, ZM Jaffer, D Stepanova, DA Campbell, ...
Cancer research 72 (22), 5966-5975, 2012
1192012
Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer
AM Jubb, EJ Soilleux, H Turley, G Steers, A Parker, I Low, J Blades, JL Li, ...
The American journal of pathology 176 (4), 2019-2028, 2010
1082010
EphB2 is a prognostic factor in colorectal cancer
AM Jubb, F Zhong, S Bheddah, HI Grabsch, GD Frantz, W Mueller, V Kavi, ...
Clinical Cancer Research 11 (14), 5181-5187, 2005
1082005
The system can't perform the operation now. Try again later.
Articles 1–20